Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M
Regina Elena Cancer Institute, Rome, Italy.
Gut. 2001 Jun;48(6):812-5. doi: 10.1136/gut.48.6.812.
Colorectal cancer is one of the leading causes of death from cancer in Western countries. Removal of adenomas is based on the assumption that it could lead to a reduction in the incidence of colorectal cancer, as demonstrated by the National Polyp Study in the USA. A critical issue is whether the benefit observed in clinical trials can also be observed in standard clinical practice. To address the issue, a multicentre Italian collaborative study was organised.
The study cohort comprised 1693 subjects of both sexes, aged 40-69 years, enrolled between 1980 and 1987 following a total colon examination (TCE) (that is, total colonoscopy or colonoscopy and double contrast barium enema), with removal of at least one adenoma larger than 5 mm in diameter. Exclusion criteria were genetic syndromes, previous adenomas or colorectal cancer, previous colonic resection, inflammatory bowel disease, or sessile adenomas more than 3 cm in diameter. Follow up ended in December 1996 by TCE or telephone interview, and review of the medical records, clinical files, or death certificates. Incidence ratios for colorectal cancer were compared with expected age and sex specific incidences in the Italian general population.
Follow up data were obtained for 97.3% of cases for a total of 14 211 person/years. Mean follow up was 10.5 years. Six colorectal cancer cases (four in males, two in females) at various stages were ascertained (one at 29 months, two at five years, one at seven years, one at eight years, and one at 10 years from the index examination). The number of cancers expected in the reference population was 17.7 for an incidence ratio of 0.34 (confidence interval 0.23-0.63; p<0.01).
Colonoscopic polypectomy substantially reduced the incidence of colorectal cancer in the cohort compared with that expected in the general population. These results are of particular relevance considering that those with adenomas are at increased risk of colorectal cancer and that this retrospective study was performed on data obtained in standard clinical practice. This observation strengthens the concept of effective population screening in view of the fact that adenomatous polyps are the most frequent neoplastic outcome of screening and their removal is associated with a decrease in the incidence of colorectal cancer.
在西方国家,结直肠癌是癌症死亡的主要原因之一。腺瘤切除基于这样一种假设,即它可能导致结直肠癌发病率降低,美国国家息肉研究已证实这一点。一个关键问题是,临床试验中观察到的益处能否在标准临床实践中也被观察到。为解决该问题,组织了一项意大利多中心合作研究。
研究队列包括1693名年龄在40 - 69岁之间的男女受试者,他们于1980年至1987年间在接受全结肠检查(TCE)(即全结肠镜检查或结肠镜检查及双重对比钡灌肠)后入组,且切除了至少一个直径大于5毫米的腺瘤。排除标准为遗传综合征、既往有腺瘤或结直肠癌、既往有结肠切除术、炎症性肠病或直径大于3厘米的无蒂腺瘤。随访于1996年12月通过TCE或电话访谈以及查阅病历、临床档案或死亡证明结束。将结直肠癌的发病率与意大利普通人群按年龄和性别划分的预期发病率进行比较。
共获得97.3%病例的随访数据,总计14211人年。平均随访时间为10.5年。确定了6例处于不同阶段的结直肠癌病例(4例男性,2例女性)(分别在索引检查后的29个月、5年、7年、8年和10年各有1例)。参考人群中预期的癌症病例数为17.7例,发病率比为0.34(置信区间0.23 - 0.63;p<0.01)。
与普通人群预期情况相比,结肠镜息肉切除术显著降低了队列中结直肠癌的发病率。鉴于患有腺瘤的人群患结直肠癌的风险增加,且这项回顾性研究是基于标准临床实践中获得的数据进行的,这些结果具有特别重要的意义。鉴于腺瘤性息肉是筛查中最常见的肿瘤性结果,且切除腺瘤与结直肠癌发病率降低相关,这一观察结果强化了有效人群筛查的概念。